Clinical Trial Update: A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the safety and preliminary efficacy of PF-00547659 in patients with active ulcerative colitis and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PF-00547659

Snippet

Sponsor: Pfizer | Conditions: Colitis, Ulcerative | Phase 1 | Status: COMPLETED